Abstract
Background Obesity is a global health problem that affects millions of people around the world, especially children and adolescents. The main causes of obesity are a sedentary lifestyle, unhealthy diet, and lack of reduction in the level of physical activity with negative consequences for physical and mental health, such as increased risk of cardiovascular diseases, diabetes, hypertension, dyslipidemia, and inflammation. Therefore, we will carry out a perform a systematic review to evaluate the effectiveness of physical activity in obese children and adolescents and serum interleukin-10 levels.
Methods This protocol is based on recommendations from the Cochrane Collaboration on the steps of a systematic review. A literature search will be performed on the following database: PubMed, the Cochrane Library, LILACS (VHL), and Google Scholar. According to the Cochrane Risk of Bias Tool and the level of evidence for results, we will assess the quality of the included studies by using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) method. The Review Manager (v5.3) software will be applied to statistical analysis.
Results From the study, we will evaluate the effectiveness of physical activity in obese children and adolescents and serum IL-10 levels correlated with age, ethnicity, sex, and body mass index (BMI).PROSPERO registration number: CRD42022355721
Strengths and limitations of this study This article emphasizes the importance of evaluating the effectiveness of physical activity in obese children and adolescents and provides methodological guidance for evaluating clinical evidence. This study 1)provides a research protocol, 2) facilitates reasonable assessment of physical activity in obese children and adolescents and serum IL-10 levels 3) increases the potential importance of recommending physical activity in obese children and adolescents to improve serum levels of IL-10, which in turn has an immunoprotective effect. The lack of reports of these effects may be limited by the small sample size.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding: No financing
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Abbreviations
- RCT
- randomized controlled trials
- GRADE
- Grading of Recommendations Assessment Development and Evaluation
- NCDs
- Chronic Noncommunicable Diseases
